Monarch Strategic
  • Business
  • Stock
  • Investing
  • Politics
Business

Musk’s brain implant company filed as a ‘disadvantaged business’

by admin July 20, 2025
July 20, 2025

Elon Musk’s health tech company Neuralink labeled itself a “small disadvantaged business” in a federal filing with the U.S. Small Business Administration, shortly before a financing round valued the company at $9 billion.

Neuralink is developing a brain-computer interface (BCI) system, with an initial aim to help people with severe paralysis regain some independence. BCI technology broadly can translate a person’s brain signals into commands that allow them to manipulate external technologies just by thinking.

Neuralink’s filing, dated April 24, would have reached the SBA at a time when Musk was leading the Trump administration’s Department of Government Efficiency. At DOGE, Musk worked to slash the size of federal agencies.

MuskWatch first reported on the details of Neuralink’s April filing.

According to the SBA’s website, a designation of SDB means a company is at least 51% owned and controlled by one or more “disadvantaged” persons who must be “socially disadvantaged and economically disadvantaged.” An SDB designation can also help a business “gain preferential access to federal procurement opportunities,” the SBA website says.

The Department of Justice has previously fined companies for making false claims about their SDB status.

Musk, the world’s wealthiest person, is CEO of Tesla and SpaceX, in addition to his other businesses like artificial intelligence startup xAI and tunneling venture The Boring Company. In 2022, Musk led the $44 billion purchase of Twitter, which he later named X before merging it with xAI.

Jared Birchall, a Neuralink executive, was listed as the contact person on the filing from April. Birchall, who also manages Musk’s money as head of his family office, didn’t immediately respond to a request for comment.

Neuralink, which incorporated in Nevada, closed a $650 million funding round in early June at a $9 billion valuation. ARK Invest, Peter Thiel’s Founders Fund, Sequoia Capital and Thrive Capital were among the investors. Neuralink said the fresh capital would help the company bring its technology to more patients and develop new devices that “deepen the connection between biological and artificial intelligence.”

Under Musk’s leadership at DOGE, the initiative took aim at government agencies that emphasized diversity, equity and inclusion (DEI). In February, for example, DOGE and Musk boasted of nixing hundreds of millions of dollars worth of funding for the Department of Education that would have gone towards DEI-related training grants.

This post appeared first on NBC NEWS

previous post
Three Stocks in Focus: One Old Favorite, One Mag Name, and a Dow Comeback Story
next post
‘Get a job’: Medicaid work requirements included in Trump’s megabill sparks partisan debate on Capitol Hill

You may also like

A flagging U.S. industry looks for new life...

July 19, 2025

Trump says it’s ‘highly unlikely’ he will fire...

July 18, 2025

Coca-Cola dodges after Trump says soda will switch...

July 18, 2025

Inflation picks up again in June as tariffs...

July 17, 2025

Jerome Powell asks inspector general to review Fed’s...

July 15, 2025

Some Walmart garment orders from Bangladesh on hold...

July 14, 2025

Trump’s tariffs on Brazil could make your coffee...

July 12, 2025

Italian chocolate giant Ferrero to buy Kellogg’s Froot...

July 11, 2025

White House accuses Powell of mismanaging Federal Reserve,...

July 11, 2025

Sports executive charged with bid-rigging in Texas arena...

July 11, 2025

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Stock

    • Week Ahead: NIFTY Violates Short-Term Supports; Stays Tentative Devoid Of Any Major Triggers

      July 20, 2025
    • The Best Five Sectors, #28

      July 20, 2025
    • ‘Get a job’: Medicaid work requirements included in Trump’s megabill sparks partisan debate on Capitol Hill

      July 20, 2025
    • Tech 5: TSMC, ASML Release Latest Results, NVIDIA to Resume Sales to China

      July 20, 2025
    • Musk’s brain implant company filed as a ‘disadvantaged business’

      July 20, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 monarchstrategic.com | All Rights Reserved

    Monarch Strategic
    • Business
    • Stock
    • Investing
    • Politics